Cargando...

Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma

Chemo/radiotherapies are the most common adjuvant modality treated for patients with glioblastoma (GBM) following surgery. However, the overall therapeutic benefits are still uncertain, as the mortality remains high. Elevated expression of YKL-40 in GBM was correlated with increases in mural cell-as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shao, Rong, Francescone, Ralph, Ngernyuang, Nipaporn, Bentley, Brooke, Taylor, Sherry L., Moral, Luis, Yan, Wei
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908752/
https://ncbi.nlm.nih.gov/pubmed/24282289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt380
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!